Ireland-Aspire
This is the first nationally representative Irish study of secondary prevention among patients with CHD. Over 600 patients were enrolled at 9 sites across Ireland, with the results presented at the 2019 Irish Cardiac Society meeting.
091 893299
info@nipc.ie
